Development of Ligands and Degraders Targeting MAGE-A3
Journal of the American Chemical Society · 2024
DOI: 10.1021/jacs.4c05393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2024. Verfasst von Ke Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06511, United States. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Neoplasm Proteins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: NIGMS NIH HHS, NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06511, United States.
- Department of Chemistry, Yale University, New Haven, Connecticut 06511, United States.
- Department of Pharmacology, Yale University, New Haven, Connecticut 06511, United States.
ORCID-Profile: Mackenzie W Krone, Craig M Crews
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Cancer Institute
Zitieren
APA
Li, K., Krone, M. W., Butrin, A., Bond, M. J., Linhares, B. M., & Crews, C. M. (2024). Development of Ligands and Degraders Targeting MAGE-A3. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c05393
Vancouver
Li K, Krone MW, Butrin A, Bond MJ, Linhares BM, Crews CM. Development of Ligands and Degraders Targeting MAGE-A3. Journal of the American Chemical Society. 2024. doi:10.1021/jacs.4c05393
BibTeX
@article{Li2024,
author = {Li, Ke and Krone, Mackenzie W and Butrin, Arseniy and Bond, Michael J and Linhares, Brian M and Crews, Craig M},
title = {Development of Ligands and Degraders Targeting MAGE-A3},
journal = {Journal of the American Chemical Society},
year = {2024},
doi = {10.1021/jacs.4c05393}
}
EUVIMED